Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Ticker symbol: ALOPM), a biopharmaceutical company specializing in precision medicine for the treatment of resistant and ...

The 14th ISABS and Mayo Clinic Conference will showcase how artificial intelligence is transforming precision medicine, ...

According to Dr. Jennifer Levin Carter, MD, founder and CEO of Medzown, the concept of personalized medicine shifted from a ...

Detroit-based Henry Ford Health has formed a joint venture with BAMF Health to expand access to precision diagnostics and treatment for patients in the region. Under the partnership, the organizations ...

Policy, precision medicine, and new ways of delivering therapeutics were popular topics in 2025 among readers of Evidence-Based Oncology ™ (EBO), the multistakeholder cancer care publication of The ...

Together, these forces position radiopharma as a frontier of medical innovation with ripple effects across healthcare, ...

GSK announced it has entered a multi-year strategic collaboration agreement with Helix aiming to drive the development of ...

Medzown (“Medzown” or the “Company”), a precision medicine management company focused on improving access to advanced therapies and clinical trials for patients with ...

Precision medicine tailors healthcare to an individual’s genes, environment, and lifestyle, moving beyond a one-size-fits-all approach. Health insurance coverage significantly impacts access to ...

Geoffrey S. Ginsburg ( [email protected]) is director of the Duke Center for Applied Genomics and Precision Medicine, Duke University, in Durham, North Carolina. Kathryn A. Phillips is a professor of ...

Precision medicine is one of the most promising and novel approaches to controlling excessive healthcare costs and providing a meaningful benefit through improved disease diagnosis, treatment and ...